FDA
-
-
-
-
-
-
-
TRICARE West expands coverage for depression treatment to teens 15+
-
-
-
-
-
-
-
Neuronetics Reports Second Quarter 2025 Financial and Operating Results
-
-
-
-
-
-
-
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
-
-
-
-
-
-
-
Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
-
-
-
-
-
-
-
Neuronetics Provides Business Update and Issues 2025 Guidance
-
-
-
-
-
-
-
Neuronetics (STIM) Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression
-
-
-
-
-
-
-
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

